GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $871,000 | 0.0% | 20,000 | 0.0% | 1.26% | +39.0% |
| Q1 2022 | $871,000 | -1.2% | 20,000 | 0.0% | 0.91% | +12.5% |
| Q4 2021 | $882,000 | +15.4% | 20,000 | 0.0% | 0.81% | +19.0% |
| Q3 2021 | $764,000 | -4.0% | 20,000 | 0.0% | 0.68% | +1.8% |
| Q2 2021 | $796,000 | +11.5% | 20,000 | 0.0% | 0.67% | +6.4% |
| Q1 2021 | $714,000 | +2.1% | 20,000 | +5.3% | 0.63% | +1.8% |
| Q4 2020 | $699,000 | +16.1% | 19,000 | +18.8% | 0.62% | -5.8% |
| Q3 2020 | $602,000 | -1.6% | 16,000 | +6.7% | 0.66% | -5.3% |
| Q2 2020 | $612,000 | +7.7% | 15,000 | 0.0% | 0.69% | -9.5% |
| Q1 2020 | $568,000 | -19.4% | 15,000 | 0.0% | 0.76% | +1.7% |
| Q4 2019 | $705,000 | +3.2% | 15,000 | -6.2% | 0.75% | -11.7% |
| Q3 2019 | $683,000 | +6.7% | 16,000 | 0.0% | 0.85% | +23.1% |
| Q2 2019 | $640,000 | -4.3% | 16,000 | 0.0% | 0.69% | +4.5% |
| Q1 2019 | $669,000 | +9.5% | 16,000 | 0.0% | 0.66% | -13.6% |
| Q4 2018 | $611,000 | -5.0% | 16,000 | 0.0% | 0.77% | +12.2% |
| Q3 2018 | $643,000 | -0.3% | 16,000 | 0.0% | 0.68% | +4.8% |
| Q2 2018 | $645,000 | +3.2% | 16,000 | 0.0% | 0.65% | -13.2% |
| Q1 2018 | $625,000 | -11.8% | 16,000 | -20.0% | 0.75% | -15.8% |
| Q4 2017 | $709,000 | +16.4% | 20,000 | +33.3% | 0.89% | +39.6% |
| Q3 2017 | $609,000 | -64.7% | 15,000 | -62.5% | 0.64% | -63.1% |
| Q2 2017 | $1,725,000 | -25.6% | 40,000 | -27.3% | 1.73% | -26.2% |
| Q1 2017 | $2,319,000 | +20.4% | 55,000 | +10.0% | 2.34% | +7.7% |
| Q4 2016 | $1,926,000 | +11.7% | 50,000 | +25.0% | 2.18% | +17.3% |
| Q3 2016 | $1,725,000 | -0.5% | 40,000 | 0.0% | 1.86% | -6.5% |
| Q2 2016 | $1,734,000 | +6.9% | 40,000 | 0.0% | 1.98% | +9.1% |
| Q1 2016 | $1,622,000 | -26.9% | 40,000 | -27.3% | 1.82% | -27.5% |
| Q4 2015 | $2,219,000 | +4.9% | 55,000 | 0.0% | 2.51% | +3.5% |
| Q3 2015 | $2,115,000 | +8.0% | 55,000 | +17.0% | 2.42% | +22.8% |
| Q2 2015 | $1,958,000 | -5.7% | 47,000 | +4.4% | 1.98% | -3.7% |
| Q1 2015 | $2,077,000 | +247.3% | 45,000 | +221.4% | 2.05% | +224.5% |
| Q4 2014 | $598,000 | -7.1% | 14,000 | 0.0% | 0.63% | +4.8% |
| Q3 2014 | $644,000 | -4.5% | 14,000 | +11.1% | 0.60% | -10.7% |
| Q2 2014 | $674,000 | +0.1% | 12,600 | 0.0% | 0.68% | +1.8% |
| Q1 2014 | $673,000 | 0.0% | 12,600 | 0.0% | 0.66% | +11.1% |
| Q4 2013 | $673,000 | +11.8% | 12,600 | +5.0% | 0.60% | +17.3% |
| Q3 2013 | $602,000 | -76.8% | 12,000 | -76.9% | 0.51% | -76.9% |
| Q2 2013 | $2,598,000 | – | 52,000 | – | 2.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |